Pharmacokinetics of escitalopram in subjects with hepatic impairment

被引：0
|
作者：
Areberg, J [1 ]
Christophersen, JS [1 ]
Poulsen, MN [1 ]
Larsen, F [1 ]
机构：
[1] H Lundbeck & Co AS, Copenhagen, Denmark
来源：
NORDIC JOURNAL OF PSYCHIATRY | 2005年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [1] The pharmacokinetics of escitalopram in patients with hepatic impairment
    Areberg, J
    Christophersen, JS
    Poulsen, MN
    Larsen, F
    Molz, KH
    [J]. AAPS JOURNAL, 2006, 8 (01): : E14 - E19
  • [2] The pharmacokinetics of escitalopram in patients with hepatic impairment
    Johan Areberg
    Jacob Strøyer Christophersen
    Mette Nøhr Poulsen
    Frank Larsen
    Karl-Heinz Molz
    [J]. The AAPS Journal, 8
  • [3] Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment
    Marzin, Kristell
    Kretschmar, Gunther
    Luedtke, Doreen
    Kraemer, Sandrine
    Kuelzer, Raimund
    Schlenker-Herceg, Rozsa
    Schmid, Ulrike
    Schnell, David
    Dallinger, Claudia
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (03): : 357 - 363
  • [4] Pharmacokinetics Of Nintedanib In Subjects With Hepatic Impairment
    Marzin, K.
    Kretschmar, G.
    Schlenker-Herceg, R.
    Dallinger, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [5] Pharmacokinetics of nelfinavir in subjects with hepatic impairment
    Damle, Bharat
    Hewlett, Dial, Jr.
    Hsyu, Poe-Hirr
    Becker, Mark
    Petersen, Annkatrin
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11): : 1241 - 1249
  • [6] Pharmacokinetics of Ribociclib in Subjects With Hepatic Impairment
    Samant, Tanay S.
    Yang, Shu
    Miller, Michelle
    Ji, Yan
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (08): : 1001 - 1009
  • [7] Pharmacokinetics of linagliptin in subjects with hepatic impairment
    Graefe-Mody, Ulrike
    Rose, Peter
    Retlich, Silke
    Ring, Arne
    Waldhauser, Lisa
    Cinca, Rodica
    Woerle, Hans-Juergen
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (01) : 75 - 85
  • [8] Pharmacokinetics of Imeglimin in Subjects with Moderate Hepatic Impairment
    Chevalier, Clemence
    Dubourg, Julie
    Bolze, Sebastien
    Fouqueray, Pascale
    [J]. CLINICAL PHARMACOKINETICS, 2021, 60 (04) : 485 - 490
  • [9] Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment
    Jamieson, Brian D.
    Ciric, Sabrina
    Fernandes, Prabhavathi
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) : 4379 - 4386
  • [10] Pharmacokinetics and Safety of Teneligliptin in Subjects With Hepatic Impairment
    Halabi, Atef
    Maatouk, Haidar
    Siegler, Karl Ernst
    Faisst, Nadja
    Hinrichsen, Holger
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (04): : 290 - 296
12345